Suprachiasmatic Modulation of Noradrenaline Release in the Ventrolateral Preoptic Nucleus
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Scale-Free Dynamics of the Mouse Wakefulness and Sleep Electroencephalogram Quantified Using Wavelet-Leaders
Article Scale-Free Dynamics of the Mouse Wakefulness and Sleep Electroencephalogram Quantified Using Wavelet-Leaders Jean-Marc Lina 1,2,3, Emma Kate O’Callaghan 1,4 and Valérie Mongrain 1,4,* 1 Research Centre and Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd., Montreal, QC H4J 1C5, Canada 2 Centre de Recherches Mathématiques, Université de Montréal, C.P. 6128, succ. Centre-Ville, Montreal, QC H3C 3J7, Canada; [email protected] 3 École de Technologie Supérieure, 1100 rue Notre-Dame Ouest, Montreal, QC H3C 1K3, Canada 4 Department of Neuroscience, Université de Montréal, C.P. 6128, succ. Centre-Ville, Montreal, QC H3C 3J7, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-514-338-2222 (ext. 3323) Received: 14 August 2018; Accepted: 11 October 2018; Published: 20 October 2018 Abstract: Scale-free analysis of brain activity reveals a complexity of synchronous neuronal firing which is different from that assessed using classic rhythmic quantifications such as spectral analysis of the electroencephalogram (EEG). In humans, scale-free activity of the EEG depends on the behavioral state and reflects cognitive processes. We aimed to verify if fractal patterns of the mouse EEG also show variations with behavioral states and topography, and to identify molecular determinants of brain scale-free activity using the ‘multifractal formalism’ (Wavelet-Leaders). We found that scale-free activity was more anti-persistent (i.e., more different between time scales) during wakefulness, less anti-persistent (i.e., less different between time scales) during non-rapid eye movement sleep, and generally intermediate during rapid eye movement sleep. -
The Superior Colliculus–Pretectum Mediates the Direct Effects of Light on Sleep
Proc. Natl. Acad. Sci. USA Vol. 95, pp. 8957–8962, July 1998 Neurobiology The superior colliculus–pretectum mediates the direct effects of light on sleep ANN M. MILLER*, WILLIAM H. OBERMEYER†,MARY BEHAN‡, AND RUTH M. BENCA†§ *Neuroscience Training Program and †Department of Psychiatry, University of Wisconsin–Madison, 6001 Research Park Boulevard, Madison, WI 53719; and ‡Department of Comparative Biosciences, University of Wisconsin–Madison, Room 3466, Veterinary Medicine Building, 2015 Linden Drive West, Madison, WI 53706 Communicated by James M. Sprague, The University of Pennsylvania School of Medicine, Philadelphia, PA, May 27, 1998 (received for review August 26, 1997) ABSTRACT Light and dark have immediate effects on greater REM sleep expression occurring in light rather than sleep and wakefulness in mammals, but the neural mecha- dark periods (8, 9). nisms underlying these effects are poorly understood. Lesions Another behavioral response of nocturnal rodents to of the visual cortex or the superior colliculus–pretectal area changes in lighting conditions consists of increased amounts of were performed in albino rats to determine retinorecipient non-REM (NREM) sleep and total sleep after lights-on and areas that mediate the effects of light on behavior, including increased wakefulness following lights-off (4). None of the rapid eye movement sleep triggering by lights-off and redis- light-induced behaviors (i.e., REM sleep, NREM sleep, or tribution of non-rapid eye movement sleep in short light–dark waking responses to lighting changes) appears to be under cycles. Acute responses to changes in light conditions were primary circadian control: the behaviors are not eliminated by virtually eliminated by superior colliculus-pretectal area le- destruction of the suprachiasmatic nucleus (24) and can be sions but not by visual cortex lesions. -
An Electrophysiological Marker of Arousal Level in Humans
RESEARCH ARTICLE An electrophysiological marker of arousal level in humans Janna D Lendner1,2*, Randolph F Helfrich3,4, Bryce A Mander5, Luis Romundstad6, Jack J Lin7, Matthew P Walker1,8, Pal G Larsson9, Robert T Knight1,8 1Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, United States; 2Department of Anesthesiology and Intensive Care Medicine, University Medical Center Tuebingen, Tuebingen, Germany; 3Hertie-Institute for Clinical Brain Research, Tuebingen, Germany; 4Department of Neurology and Epileptology, University Medical Center Tuebingen, Tuebingen, Germany; 5Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, United States; 6Department of Anesthesiology, University of Oslo Medical Center, Oslo, Norway; 7Department of Neurology, University of California, Irvine, Irvine, United States; 8Department of Psychology, University of California, Berkeley, Berkeley, United States; 9Department of Neurosurgery, University of Oslo Medical Center, Oslo, Norway Abstract Deep non-rapid eye movement sleep (NREM) and general anesthesia with propofol are prominent states of reduced arousal linked to the occurrence of synchronized oscillations in the electroencephalogram (EEG). Although rapid eye movement (REM) sleep is also associated with diminished arousal levels, it is characterized by a desynchronized, ‘wake-like’ EEG. This observation implies that reduced arousal states are not necessarily only defined by synchronous oscillatory activity. Using intracranial and surface EEG recordings in four independent data sets, we demonstrate that the 1/f spectral slope of the electrophysiological power spectrum, which reflects the non-oscillatory, scale-free component of neural activity, delineates wakefulness from propofol *For correspondence: anesthesia, NREM and REM sleep. Critically, the spectral slope discriminates wakefulness from [email protected] REM sleep solely based on the neurophysiological brain state. -
Deconstructing Arousal Into Wakeful, Autonomic and Affective Varieties
Neuroscience Letters xxx (xxxx) xxx–xxx Contents lists available at ScienceDirect Neuroscience Letters journal homepage: www.elsevier.com/locate/neulet Review article Deconstructing arousal into wakeful, autonomic and affective varieties ⁎ Ajay B. Satputea,b, , Philip A. Kragelc,d, Lisa Feldman Barrettb,e,f,g, Tor D. Wagerc,d, ⁎⁎ Marta Bianciardie,f, a Departments of Psychology and Neuroscience, Pomona College, Claremont, CA, USA b Department of Psychology, Northeastern University, Boston, MA, USA c Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, USA d The Institute of Cognitive Science, University of Colorado Boulder, Boulder, USA e Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA, USA f Department of Radiology, Harvard Medical School, Boston, MA, USA g Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA ARTICLE INFO ABSTRACT Keywords: Arousal plays a central role in a wide variety of phenomena, including wakefulness, autonomic function, affect Brainstem and emotion. Despite its importance, it remains unclear as to how the neural mechanisms for arousal are or- Arousal ganized across them. In this article, we review neuroscience findings for three of the most common origins of Sleep arousal: wakeful arousal, autonomic arousal, and affective arousal. Our review makes two overarching points. Autonomic First, research conducted primarily in non-human animals underscores the importance of several subcortical Affect nuclei that contribute to various sources of arousal, motivating the need for an integrative framework. Thus, we Wakefulness outline an integrative neural reference space as a key first step in developing a more systematic understanding of central nervous system contributions to arousal. -
MWT Review Paper.Qxp 12/30/2004 8:46 AM Page 123
MWT review paper.qxp 12/30/2004 8:46 AM Page 123 REVIEW PAPER The Clinical Use of the MSLT and MWT Donna Arand, Ph.D1, Michael Bonnet, Ph.D2, Thomas Hurwitz, M.D3, Merrill Mitler, Ph.D4, Roger Rosa, Ph.D5 and R. Bart Sangal, M.D6 1 Kettering Medical Center, Dayton, OH, 2Dayton Veteran’s Affairs Medical Center and Wright State University, Dayton, OH, 3Minneapolis Veteran’s Affairs Medical Center and University of Minnesota, Minneapolis, MN, 4National Institute of Neurological Disorders & Stroke Neuroscience Center, Bethesda, MD, 5National Institute for Occupational Safety and Health, Washington, DC, 6Sleep Disorders Institute, Troy, MI Citation: Review by the MSLT and MWT Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. SLEEP 2005;28(1):123-144. 1.0 INTRODUCTION ness and to assess the database of evidence for the clinical use of the MSLT and MWT. EXCESSIVE SLEEPINESS IS DEFINED AS SLEEPINESS OCCURRING IN A SITUATION WHEN AN INDIVIDUAL 2.0 BACKGROUND WOULD BE EXPECTED TO BE AWAKE AND ALERT. It is a chronic problem for about 5% of the general population,1, 2 and it 2.1 History of the Development of MSLT and MWT is the most common complaint evaluated by sleep disorder cen- Initially, definitions involving sleep onset were based on ters.1, 3 The most common causes of sleepiness include partial sleep deprivation, fragmented sleep and medication effects. behavioral observations that often depended on features such as Sleepiness is also associated with sleep disorders such as sleep lack of movement, unresponsiveness, snoring, etc. -
Pharmacological Management of Disrupted Sleep Due to Methamphetamine Use: a Literature Review
Journal of Psychology and Clinical Psychiatry Literature Review Open Access Pharmacological management of disrupted sleep due to Methamphetamine use: a literature review Abstract Volume 11 Issue 5 - 2020 Objective: To review the literature on pharmacological management of disrupted sleeping Jagdeep Kaur,1 Kawish Garg2 patterns due to Methamphetamine use. 1Clinical Director of MAT Services, Keystone Behavioral Health Data sources: A PubMed search of human studies published in English through July 2020 Services, USA 2 was conducted using the broad search terms “Methamphetamine” and “Sleep”. Medical Director of Sleep Medicine, Geisinger Holy Spirit, USA Study selection: 105 articles were identified and reviewed; 2 studies met the inclusion Correspondence: Kawish Garg, Medical Director of Sleep criteria. Medicine, Geisinger Holy Spirit, 550 North 12th St Lemoyne, PA 17043, USA, Tel 717-975-8585, Email Data extraction: Study design, sample size, medications dose and duration, and sleep related outcomes were reviewed. Received: September 10, 2020 | Published: September 23, 2020 Data synthesis: This is some evidence for Modafinil and Mirtazapine for disrupted sleep due to Methamphetamine use, however it is limited by small sample size of the studies. Conclusion: Treatment of disrupted sleep due to Methamphetamine use, remains challenging. Modafinil and mirtazapine appear to show promise, but further research is warranted before making any evidence-based recommendations. Keywords: methamphetamine, sleep Abbreviations: NSDUH, national survey on -
Potential Brain Neuronal Targets for Amphetamine-, Methylphenidate
Proc. Natl. Acad. Sci. USA Vol. 93, pp. 14128–14133, November 1996 Neurobiology Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat (immediate-early geneyprotooncogeneyanterior hypothalamic nucleusystriatumydopaminergic system) JIANG-SHENG LIN*, YIPING HOU, AND MICHEL JOUVET De´partementde Me´decineExpe´rimentale, Institut National de la Sante´et de la Recherche Me´dicaleUnite´52, Centre National de la Recherche Scientifique ERS 5645, Faculte´deMe´decine, Universite´Claude Bernard, 8 avenue Rockefeller, 69373 Lyon, France Communicated by Jean-Pierre Changeux, Institut Pasteur, Paris, France, August 29, 1996 (received for review July 29, 1996) ABSTRACT Much experimental and clinical data suggest expression of IEGs occurs in the brain, c-fos is strongly expressed that the pharmacological profile of modafinil, a newly dis- in various specific cerebral areas following different stimuli, such covered waking substance, differs from those of amphetamine as electrical or pharmacological stimulation, stress, or sleep and methylphenidate, two classical psychostimulants. The deprivation (8–15). Thus, visualization of c-fos could serve as a brain targets on which modafinil acts to induce wakefulness, sensitive indicator of gene activation in individual target neurons however, remain unknown. A double-blind study using the activated following a given stimulus. protooncogene c-fos as experimental marker in the cat was, We have, therefore, developed Fos immunocytochemical pro- therefore, carried out to identify the potential target neurons cedures in both the rat and cat to visualize the potential targets of modafinil and compare them with those for amphetamine of modafinil and amphetamine in the central nervous system. -
Molecular and Cellular Networks in the Suprachiasmatic Nuclei
International Journal of Molecular Sciences Review Molecular and Cellular Networks in The Suprachiasmatic Nuclei Lama El Cheikh Hussein, Patrice Mollard and Xavier Bonnefont * Institut de Génomique Fonctionnelle (IGF), University Montpellier, CNRS, INSERM, 34094 Montpellier, France; [email protected] (L.E.C.H.); [email protected] (P.M.) * Correspondence: [email protected]; Tel.: +33-4-3435-9306 Received: 1 April 2019; Accepted: 23 April 2019; Published: 25 April 2019 Abstract: Why do we experience the ailments of jetlag when we travel across time zones? Why is working night-shifts so detrimental to our health? In other words, why can’t we readily choose and stick to non-24 h rhythms? Actually, our daily behavior and physiology do not simply result from the passive reaction of our organism to the external cycle of days and nights. Instead, an internal clock drives the variations in our bodily functions with a period close to 24 h, which is supposed to enhance fitness to regular and predictable changes of our natural environment. This so-called circadian clock relies on a molecular mechanism that generates rhythmicity in virtually all of our cells. However, the robustness of the circadian clock and its resilience to phase shifts emerge from the interaction between cell-autonomous oscillators within the suprachiasmatic nuclei (SCN) of the hypothalamus. Thus, managing jetlag and other circadian disorders will undoubtedly require extensive knowledge of the functional organization of SCN cell networks. Here, we review the molecular and cellular principles of circadian timekeeping, and their integration in the multi-cellular complexity of the SCN. -
Cholinergic Regulation of the Suprachiasmatic Nucleus Circadian Rhythm Via a Muscarinic Mechanism at Night
The Journal of Neuroscience, January 15, 1996, 16(2):744-751 Cholinergic Regulation of the Suprachiasmatic Nucleus Circadian Rhythm via a Muscarinic Mechanism at Night Chen Liul and Martha U. Gillette’,2,3 1Neuroscience Program, and Departments of 2Cell and Structural Biology and 3Physiology, University of Illinois at Urbana-Champaign, Urbana, Illinois 6 180 I In mammals, the suprachiasmatic nucleus (SCN) is responsible for agonists, muscarine and McN-A-343 (Ml-selective), but not by the generation of most circadian rhythms and for their entrainment nicotine. Furthermore, the effect of carbachol was blocked by the to environmental cues. Carbachol, an agonist of acetylcholine mAChR antagonist atropine (0.1 PM), not by two nicotinic antag- (ACh), has been shown to shift the phase of circadian rhythms in onists, dihydro-6-erythroidine (10 PM) and d-tubocurarine (10 PM). rodents when injected intracerebroventricularly. However, the site The Ml -selective mAChR antagonist pirenzepine completely and receptor type mediating this action have been unknown. In blocked the carbachol effect at 1 PM, whereas an M3-selective the present experiments, we used the hypothalamic brain-slice antagonist, 4,2-(4,4’-diacetoxydiphenylmethyl)pyridine, partially technique to study the regulation of the SCN circadian rhythm of blocked the effect at the same concentration. These results dem- neuronal firing rate by cholinergic agonists and to identify the onstrate that carbachol acts directly on the SCN to reset the receptor subtypes involved. We found that the phase of the os- phase of its firing rhythm during the subjective night via an Ml -like cillation in SCN neuronal activity was reset by a 5 min treatment mAChR. -
Retinal Afferents to the Dorsal Raphe Nucleus in Rats and Mongolian Gerbils
THE JOURNAL OF COMPARATIVE NEUROLOGY 414:469–484 (1999) Retinal Afferents to the Dorsal Raphe Nucleus in Rats and Mongolian Gerbils KATHERINE V. FITE,1* SKIRMANTAS JANUSˇ ONIS,1 WARREN FOOTE,2 AND LYNN BENGSTON1 1Neuroscience and Behavior Program, University of Massachusetts, Amherst, Massachusetts 01003 2Massachusetts General Hospital, Boston, Massachusetts 02114 ABSTRACT A direct pathway from the retina to the dorsal raphe nucleus (DRN) has been demonstrated in both albino rats and Mongolian gerbils. Following intraocular injection of cholera toxin subunit B (CTB), a diffuse stream of CTB-positive, fine-caliber optic axons emerged from the optic tract at the level of the pretectum/anterior mesencephalon. In gerbils, CTB-positive axons descended ventromedially into the periaqueductal gray, moving caudally and arborizing extensively throughout the DRN. In rats, the retinal-DRN projection com- prised fewer, but larger caliber, axons, which arborized in a relatively restricted region of the lateral and ventral DRN. Following injection of CTB into the lateral DRN, retrogradely labeled ganglion cells (GCs) were observed in whole-mount retinas of both species. In gerbils, CTB-positive GCs were distributed over the entire retina, and a nearest-neighbor analysis of CTB-positive GCs showed significant regularity (nonrandomness) in their distribution. The overall distribution of gerbil GC soma diameters ranged from 8 to 22 µm and was skewed slightly towards the larger soma diameters. Based on an adaptive mixtures model statistical analysis, two Gaussian distributions appeared to comprise the total GC distribution, with mean soma diameters of 13 (SEM Ϯ1.7) µm, and 17 (SEM Ϯ1.5) µm, respectively. In rats, many fewer CTB-positive GCs were labeled following CTB injections into the lateral DRN, and nearly all occurred in the inferior retina. -
Role of the Suprachiasmatic Nucleus
Brain Research Reviews 49 (2005) 429–454 www.elsevier.com/locate/brainresrev Review Circadian regulation of sleep in mammals: Role of the suprachiasmatic nucleus Ralph E. MistlbergerT Department of Psychology, Simon Fraser University, 8888 University Drive, Burnaby, Canada BC V5A 1S6 Accepted 7 January 2005 Available online 8 March 2005 Abstract Despite significant progress in elucidating the molecular basis for circadian oscillations, the neural mechanisms by which the circadian clock organizes daily rhythms of behavioral state in mammals remain poorly understood. The objective of this review is to critically evaluate a conceptual model that views sleep expression as the outcome of opponent processes—a circadian clock-dependent alerting process that opposes sleep during the daily wake period, and a homeostatic process by which sleep drive builds during waking and is dissipated during sleep after circadian alerting declines. This model is based primarily on the evidence that in a diurnal primate, the squirrel monkey (Saimiri sciureus), ablation of the master circadian clock (the suprachiasmatic nucleus; SCN) induces a significant expansion of total daily sleep duration and a reduction in sleep latency in the dark. According to this model, the circadian clock actively promotes wake but only passively gates sleep; thus, loss of circadian clock alerting by SCN ablation impairs the ability to sustain wakefulness and causes sleep to expand. For comparison, two additional conceptual models are described, one in which the circadian clock actively promotes sleep but not wake, and a third in which the circadian clock actively promotes both sleep and wake, at different circadian phases. Sleep in intact and SCN-damaged rodents and humans is first reviewed, to determine how well the data fit these conceptual models. -
The Role of the Intergeniculate Leaflet in Entrainment of Circadian
The Journal of Neuroscience, January 1, 1999, 19(1):372–380 The Role of the Intergeniculate Leaflet in Entrainment of Circadian Rhythms to a Skeleton Photoperiod Kim Edelstein and Shimon Amir Center for Studies in Behavioral Neurobiology, Department of Psychology, Concordia University, Montreal, Quebec, Canada H3G 1M8 Mammalian circadian rhythms are synchronized to environmen- by 12 hr of darkness, but exhibited free-running rhythms when tal light/dark (LD) cycles via daily phase resetting of the circa- housed under an SPP consisting of two 1 hr light pulses given dian clock in the suprachiasmatic nucleus (SCN). Photic infor- at times corresponding to dusk and dawn. Despite IGL lesions mation is transmitted to the SCN directly from the retina via the and other damage to the visual system, the SCN displayed retinohypothalamic tract (RHT) and indirectly from the retinore- normal sensitivity to the entraining light, as assessed by light- cipient intergeniculate leaflet (IGL) via the geniculohypotha- induced Fos immunoreactivity. In addition, all IGL-lesioned, lamic tract (GHT). The RHT is thought to be both necessary and free-running rats showed masking of the body temperature sufficient for photic entrainment to standard laboratory light/ rhythm during the SPP light pulses. These results show that the dark cycles. An obligatory role for the IGL–GHT in photic en- integrity of the IGL is necessary for entrainment of circadian trainment has not been demonstrated. Here we show that the rhythms to a lighting schedule like that experienced by noctur- IGL is necessary for entrainment of circadian rhythms to a nal rodents in the natural environment.